In this report, the global Needle Free Injection Systems market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2023, growing at a CAGR of XX% between 2016 and 2023.
Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Needle Free Injection Systems for these regions, from 2012 to 2023 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India

Global Needle Free Injection Systems market competition by top manufacturers/players, with Needle Free Injection Systems sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Antares Pharma, Inc. (U.S.)
Endo International plc (U.S.)
PharmaJet (U.S)
Bioject Medical Technologies Inc. (U.S)
Medical International Technology, Inc. (U.S)
INJEX Pharma AG (Germany)
National Medical Products Inc. (U.S.)
Valeritas, Inc. (U.S.)
European Pharma Group (Netherland)
PenJet Corporation (U.S)
Crossject SA (France)
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Liquid-Based Needle-Free Injectors
Projectile/Depot-Based Needle-Free Injectors
Powder-Based Needle Free Injectors
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Needle Free Injection Systems for each application, including
Vaccine Delivery
Insulin Delivery
Oncology
Pain Management
Others

If you have any special requirements, please let us know and we will offer you the report as you want.